Cargando…
A short- and long-term follow-up study of intersphincteric NASHA Dx implants for fecal incontinence
BACKGROUND: The bulking agent NASHA Dx injected into the submucosal layer is effective in the treatment of fecal incontinence (FI) at short-and medium-term follow-up but efficacy after injection in the intersphincteric location is unknown. The aim of this study was to determine the short- and long-t...
Autores principales: | Ezra, E., Danielsson, J. M., Graf, W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458585/ https://www.ncbi.nlm.nih.gov/pubmed/35752984 http://dx.doi.org/10.1007/s10151-022-02645-6 |
Ejemplares similares
-
Long-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence
por: Mellgren, A, et al.
Publicado: (2014) -
Validity of the ≥50% Response Threshold in Treatment With NASHA/Dx Injection Therapy for Fecal Incontinence
por: Sanchez, Jaime E, et al.
Publicado: (2015) -
Identifying factors associated with clinical success in patients treated with NASHA(®)/Dx injection for fecal incontinence
por: Franklin, Howard, et al.
Publicado: (2016) -
An Open-Label, Noncomparative, Multicenter Study to Evaluate Efficacy and Safety of NASHA/Dx Gel as a Bulking Agent for the Treatment of Fecal Incontinence
por: Dodi, Giuseppe, et al.
Publicado: (2010) -
An evaluation of the long-term effectiveness of Gatekeeper™ intersphincteric implants for passive faecal incontinence
por: Jabbar, S. A. A., et al.
Publicado: (2022)